Cerus (CERS) Other Non-Current Assets (2010 - 2026)
Cerus (CERS) posted Other Non-Current Assets of $12.2 million for Q2 2026, up 8.97% sequentially from $11.2 million in Q1 2026, and little changed YoY from $12.2 million in Q2 2025.
Cerus (CERS) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Cerus has reported Other Non-Current Assets for 17 years, with the latest figure at $12.2 million in Q2 2026.
- Quarterly Other Non-Current Assets changed 0.23% year-over-year to $12.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $12.2 million (changed 0.23% YoY) and the FY2025 annual result came in at $11.0 million, down 34.24% from the prior year.
- Other Non-Current Assets climbed to $12.2 million in Q2 2026 per CERS's latest filing, from $11.2 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $24.0 million in Q2 2022 and troughed at $5.9 million in Q4 2022.
- A 5-year average of $15.0 million and a median of $12.7 million in 2024 frame the typical range for Other Non-Current Assets.
- The widest YoY moves for Other Non-Current Assets: up 173.5% in 2022, down 72.78% in 2022.
- Over 5 years, Other Non-Current Assets stood at $5.9 million in 2022, then soared by 94.17% to $11.4 million in 2023, then jumped by 47.05% to $16.8 million in 2024, then slumped by 34.24% to $11.0 million in 2025, then grew by 10.45% to $12.2 million in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $12.2 million, $11.2 million, and $11.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Cerus | 560.58 Mn | 504.32 Mn | 29.53 Mn | 12.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.20 Mn |
| Mar 31, 2026 | 11.20 Mn |
| Dec 31, 2025 | 639,000.00 |
| Sep 30, 2025 | 1.14 Mn |
| Jun 30, 2025 | 1.14 Mn |
| Mar 31, 2025 | 1.11 Mn |
| Dec 31, 2024 | 1.10 Mn |
| Sep 30, 2024 | 14.79 Mn |
| Jun 30, 2024 | 1.71 Mn |
| Mar 31, 2024 | 1.71 Mn |
| Dec 31, 2023 | 1.71 Mn |
| Sep 30, 2023 | 1.77 Mn |
| Jun 30, 2023 | 1.79 Mn |
| Mar 31, 2023 | 20.88 Mn |
| Dec 31, 2022 | 1.77 Mn |
| Sep 30, 2022 | 2.00 Mn |
| Jun 30, 2022 | 2.01 Mn |
| Mar 31, 2022 | 20.45 Mn |
| Dec 31, 2021 | 21.62 Mn |
| Sep 30, 2021 | 2.28 Mn |